Morphological and functional characterization of an in vitro blood-brain barrier model
- PMID: 9401753
- DOI: 10.1016/s0006-8993(97)00829-9
Morphological and functional characterization of an in vitro blood-brain barrier model
Abstract
Cell culture models have been extensively used for studies of blood-brain barrier (BBB) function. However, several in vitro models fail to reproduce some, if not most, of the physiological and morphological properties of in situ brain microvascular endothelial cells. We have recently developed a dynamic, tridimensional BBB model where endothelial cells exposed to intraluminal flow form a barrier to ions and proteins following prolonged co-culturing with glia. We have further characterized this cell culture model to determine whether these barrier properties were due to expression of a BBB phenotype. Endothelial cells of human, bovine or rodent origin were used. When co-cultured with glia, intraluminally grown endothelial cells developed features similar to in vivo endothelial cells, including tight junctional contacts at interdigitating processes and a high transendothelial resistance. This in vitro BBB was characterized by the expression of an abluminal, ouabain-sensitive Na/K pump, and thus favored passage of potassium ions towards the lumen while preventing K+ extravasation. Similarly, the in vitro BBB prevented the passage of blood-brain barrier-impermeant drugs (such as morphine, sucrose and mannitol) while allowing extraluminal accumulation of lipophylic substances such as theophylline. Finally, expression of stereo-selective transporters for Aspartate was revealed by tracer studies. We conclude that the in vitro dynamic BBB model may become an useful tool for the studies of BBB-function and for the testing of drug passage across the brain endothelial monolayer.
Similar articles
-
Impaired induction of blood-brain barrier properties in aortic endothelial cells by astrocytes from GFAP-deficient mice.Glia. 1998 Apr;22(4):390-400. Glia. 1998. PMID: 9517571
-
A new dynamic in vitro model for the multidimensional study of astrocyte-endothelial cell interactions at the blood-brain barrier.Brain Res. 2002 Oct 4;951(2):243-54. doi: 10.1016/s0006-8993(02)03167-0. Brain Res. 2002. PMID: 12270503
-
Immortalized human brain endothelial cells and flow-based vascular modeling: a marriage of convenience for rational neurovascular studies.J Cereb Blood Flow Metab. 2008 Feb;28(2):312-28. doi: 10.1038/sj.jcbfm.9600525. Epub 2007 Jul 4. J Cereb Blood Flow Metab. 2008. PMID: 17609686
-
Blood-brain barrier biology and methodology.J Neurovirol. 1999 Dec;5(6):556-69. doi: 10.3109/13550289909021285. J Neurovirol. 1999. PMID: 10602397 Review.
-
The cell biology of the blood-brain barrier.Annu Rev Neurosci. 1999;22:11-28. doi: 10.1146/annurev.neuro.22.1.11. Annu Rev Neurosci. 1999. PMID: 10202530 Review.
Cited by
-
Persistent SIV infection of a blood-brain barrier model.J Neurovirol. 2002 Aug;8(4):270-80. doi: 10.1080/13550280290100734. J Neurovirol. 2002. PMID: 12161812
-
Methodologies to assess drug permeation through the blood-brain barrier for pharmaceutical research.Pharm Res. 2013 Nov;30(11):2729-56. doi: 10.1007/s11095-013-1119-z. Epub 2013 Jun 26. Pharm Res. 2013. PMID: 23801086 Review.
-
Serum transthyretin monomer as a possible marker of blood-to-CSF barrier disruption.J Neurosci. 2003 Mar 1;23(5):1949-55. doi: 10.1523/JNEUROSCI.23-05-01949.2003. J Neurosci. 2003. PMID: 12629200 Free PMC article. Clinical Trial.
-
Prenatal exposure to thalidomide, altered vasculogenesis, and CNS malformations.Neuroscience. 2006 Sep 29;142(1):267-83. doi: 10.1016/j.neuroscience.2006.06.017. Epub 2006 Jul 20. Neuroscience. 2006. PMID: 16859833 Free PMC article.
-
Dendritic cells lower the permeability of endothelial monolayers.Cell Mol Bioeng. 2012 Jun;5(2):184-193. doi: 10.1007/s12195-012-0220-4. Epub 2012 Feb 4. Cell Mol Bioeng. 2012. PMID: 33968262 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous